The utilization of pleural catheters has developed exponentially, especially in the management of malignant pleural effusions, since the FDA approved their utilization in 1997. Commonly utilized, commercially available devices include Rocket IPC (Rocket Medical, England) and PleurX catheter (BD ... Read more